Clinical trials

Savara is currently conducting a pivotal Phase 3 clinical trial, IMPALA, of Molgradex for the treatment of autoimmune pulmonary alveolar proteinosis (aPAP), IMPALA-X, an open-label, safety extension study in aPAP, and a Phase 2a clinical study, OPTIMA, of Molgradex for the treatment of nontuberculous mycobacterial (NTM) infection.

Savara is also conducting a pivotal Phase 3 study, AVAIL, of AeroVanc for the treatment of MRSA in Cystic Fibrosis patients in the U.S. and Canada.

Read more

Pipeline

We are advancing a pipeline of novel inhalation therapies for the treatment of severe pulmonary conditions.

Read more

Indications

We focus on rare respiratory diseases in order to give patients with unmet medical needs better treatment options.

Read more

AeroVanc.com

Visit the AeroVanc website to learn more about MRSA in Cystic Fibrosis, AeroVanc and our pivotal Phase 3 AVAIL study

Read more

aerovanc

PAP.Info

Visit our PAP portal where patients and doctors can learn more about this disease

Read more

Back to Top
Savara Nasdaq Opening Bell Ceremony - July 23, 2018
×

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

I accept I decline
Privacy Settings
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

Analytics Nessessary Privacy Center Privacy Policy Cookie Policy
These cookies allow us to count visits and traffic sources, so we can measure and improve the performance of our site.
Google Analytics
Google Analytics works by means of tracking code that is added to the pages of our website. Every user is registered with a unique ID, so that Google Analytics can provide us with insight into how many unique visitors there are to the site, for example, and how many users return. With Google Analytics, we can survey how often any single user has visited the website, what pages they visited, for how long they stayed and how they interacted with the site.
  • __utma
  • __utmt
  • __utmb
  • __utmz
  • __utmv
Decline all Services
Accept all Services